KRT16 and psoriasis: Augmented epidermal CK16 expression is also characteristic for inflammatory skin diseases with a hyper-proliferative epidermis, such as psoriasis, and CK16 is used as marker to evaluate the efficacy of anti-psoriatic treatments [40].